About FDA
Number of documents reviewed for CT and ET policy development in the month
Dictionary: As a key agency protecting the public’s health, FDA is asked to provide input into inter and intra-agency countermeasure development activities. One coordinated voice from the agency insures consistent responses, minimizing confusion on agency policy. Consistent communication and input of agency policy minimizes opportunities for hindering the deployment of medical countermeasures to the public.
Fiscal Year - 2011
| Time | Target | Number of Documents |
|---|---|---|
| Oct 2010 | N/A | 25 |
| Nov 2010 | N/A | 17 |
| Dec 2010 | N/A | 15 |
| Jan 2011 | N/A | 10 |
| Feb 2011 | N/A | 6 |
| Mar 2011 | N/A | 9 |
| Apr 2011 | N/A | 7 |
| May 2011 | N/A | N/A |
| Jun 2011 | N/A | N/A |
| Jul 2011 | N/A | N/A |
| Aug 2011 | N/A | N/A |
| Sep 2011 | N/A | N/A |
FY 2011 7-Month Total: 89
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
